Analyzer Replaces Manual Microscopy of Blood Samples

Automated technology increases productivity, reduces response times, and improves diagnostic quality.

CellaVision AB (Lund, Sweden), which develops and sells digital morphology products for the routine analysis of blood and other body fluids, has received official approval for the new analyzer, CellaVision DM1200, in Canada. The registration was issued by the Canadian federal department Health Canada at the end of September 2009. The product has been available on the European market since July 2009.

Since 2007 CellaVision has been selling its products in Canada through a subsidiary, and more than 25 analyzers have been sold to both hospital and commercial laboratories. In the United States CellaVision sells its products both via the distributor Sysmex America (Mundelein, IL, USA) as well as through a subsidiary. As of 2008, North America accounted for 43% of CellaVision's turnover.

CellaVision AB develops, markets, and sells image analysis based systems for routine analysis of blood and other body fluids. The company develops and markets systems for automatic differentials of white blood cells and red morphology, and software for education and quality assurance of differentials.

Related Links:
CellaVision AB
Sysmex America